🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
This is a single-arm, phase II study aiming to evaluate the feasibility and...
Status
Unknown
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-05-01
Trial ID
NCT04267549
Treatments Being Tested
This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-08-19
Trial ID
NCT04892043
Treatments Being Tested
This research clinical trial is studying the creation and administration of...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2020-01-29
Trial ID
NCT04239040
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine wit...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-04
Trial ID
NCT02385669
Treatments Being Tested
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This study is investigating the optimal dose and the advantage in combining...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-08-30
Trial ID
NCT06290622
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479